东方港湾调研股大涨30%！冠军私募调研多只AI算力股！私募7月调研多只创新药股！

Core Viewpoint - The A-share market showed strong performance in July, with the Shanghai Composite Index rising by 3.74%, the Shenzhen Component Index by 5.20%, and the ChiNext Index by 8.14%, indicating a favorable market sentiment for institutional investors, including private equity funds [1] Group 1: Market Overview - In July, the market maintained high trading volumes, with margin financing balances reaching a new high for the year, reflecting a positive atmosphere for bullish investments [1] - Private equity funds have performed well this year, with an average return of 14.86%, significantly outperforming the market's return of 6.61% during the same period [1] Group 2: Institutional Research Activities - A total of 651 A-share companies were researched by institutions, with 11,554 participating institutions, and private equity funds specifically researched 306 companies with 1,142 participating private equity firms [2][4] - The most researched sectors by institutions were electronics, biomedicine, computers, and machinery, while private equity funds focused on computers, biomedicine, electronics, and power equipment [2][3] Group 3: Notable Companies and Performance - The top 20 A-share companies researched by institutions in July had a median price change of 11.93%, outperforming the broader market [5] - Notable companies such as NewEase and Zhongji Xuchuang were heavily researched, with 179 and 145 institutions respectively, and both saw price increases exceeding 40% in July [6][7] Group 4: Focus on AI and Innovative Drugs - The AI computing and innovative drug sectors were highlighted as strong performers in July, with several companies in these areas experiencing price increases of over 40% [9] - Private equity funds, including prominent firms like Fusheng Asset and Juming Investment, conducted research on companies in the AI supply chain, leading to significant stock price increases [9][15] Group 5: Prominent Private Equity Firms - Leading private equity firms such as Gao Yi Asset and Fusheng Asset conducted extensive research on multiple A-share companies, with Gao Yi researching 19 companies, primarily in the biomedicine and machinery sectors [12] - The median price change for companies researched by Gao Yi in July was 11.08%, indicating strong performance relative to the market [12] Group 6: Summary of Research Findings - A total of 27 A-share companies were researched by more than 10 private equity firms, with a median price change of 10.81% in July, again outperforming the market [7] - The research activities of top private equity firms were associated with significant stock price increases, with many companies seeing gains of over 40% [15]